Global Monoclonal Antibody Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 151775
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 120
  • list Pharmaceuticals and Healthcare

For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body.

Scope of the Report:

This report focuses on the Monoclonal Antibody Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Monoclonal Antibody Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Pfizer

Bayer

Sanofi

Merck

GlaxoSmithKline

Roche

Novartis

AbbVie

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Human

Humanized

Chimeric

Others

Market Segment by Applications, can be divided into

Hospitals

Clinics

Others

There are 15 Chapters to deeply display the global Monoclonal Antibody Therapeutics market.

Chapter 1, to describe Monoclonal Antibody Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Monoclonal Antibody Therapeutics, with sales, revenue, and price of Monoclonal Antibody Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Monoclonal Antibody Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Monoclonal Antibody Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Monoclonal Antibody Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Monoclonal Antibody Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Human

1.2.2 Humanized

1.2.3 Chimeric

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Monoclonal Antibody Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Monoclonal Antibody Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bayer

2.2.1 Business Overview

2.2.2 Monoclonal Antibody Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bayer Monoclonal Antibody Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sanofi

2.3.1 Business Overview

2.3.2 Monoclonal Antibody Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sanofi Monoclonal Antibody Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Merck

2.4.1 Business Overview

2.4.2 Monoclonal Antibody Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Merck Monoclonal Antibody Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 GlaxoSmithKline

2.5.1 Business Overview

2.5.2 Monoclonal Antibody Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Roche

2.6.1 Business Overview

2.6.2 Monoclonal Antibody Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Roche Monoclonal Antibody Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Novartis

2.7.1 Business Overview

2.7.2 Monoclonal Antibody Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Novartis Monoclonal Antibody Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 AbbVie

2.8.1 Business Overview

2.8.2 Monoclonal Antibody Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 AbbVie Monoclonal Antibody Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Monoclonal Antibody Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Monoclonal Antibody Therapeutics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Monoclonal Antibody Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Monoclonal Antibody Therapeutics Manufacturer Market Share in 2017

3.3.2 Top 6 Monoclonal Antibody Therapeutics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Monoclonal Antibody Therapeutics Market Analysis by Regions

4.1 Global Monoclonal Antibody Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global Monoclonal Antibody Therapeutics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Monoclonal Antibody Therapeutics Revenue and Market Share by Regions (2013-2018)

4.2 North America Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

4.3 Europe Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

4.5 South America Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

5 North America Monoclonal Antibody Therapeutics by Countries

5.1 North America Monoclonal Antibody Therapeutics Sales, Revenue and Market Share by Countries

5.1.1 North America Monoclonal Antibody Therapeutics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Monoclonal Antibody Therapeutics Revenue and Market Share by Countries (2013-2018)

5.2 United States Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

5.3 Canada Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

5.4 Mexico Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

6 Europe Monoclonal Antibody Therapeutics by Countries

6.1 Europe Monoclonal Antibody Therapeutics Sales, Revenue and Market Share by Countries

6.1.1 Europe Monoclonal Antibody Therapeutics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Monoclonal Antibody Therapeutics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

6.3 UK Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

6.4 France Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

6.5 Russia Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

6.6 Italy Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Monoclonal Antibody Therapeutics by Countries

7.1 Asia-Pacific Monoclonal Antibody Therapeutics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Monoclonal Antibody Therapeutics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Monoclonal Antibody Therapeutics Revenue and Market Share by Countries (2013-2018)

7.2 China Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

7.3 Japan Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

7.4 Korea Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

7.5 India Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

8 South America Monoclonal Antibody Therapeutics by Countries

8.1 South America Monoclonal Antibody Therapeutics Sales, Revenue and Market Share by Countries

8.1.1 South America Monoclonal Antibody Therapeutics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Monoclonal Antibody Therapeutics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

8.3 Argentina Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

8.4 Colombia Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Monoclonal Antibody Therapeutics by Countries

9.1 Middle East and Africa Monoclonal Antibody Therapeutics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Monoclonal Antibody Therapeutics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Monoclonal Antibody Therapeutics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

9.3 UAE Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

9.4 Egypt Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

9.5 Nigeria Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

9.6 South Africa Monoclonal Antibody Therapeutics Sales and Growth Rate (2013-2018)

10 Global Monoclonal Antibody Therapeutics Market Segment by Type

10.1 Global Monoclonal Antibody Therapeutics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Monoclonal Antibody Therapeutics Sales and Market Share by Type (2013-2018)

10.1.2 Global Monoclonal Antibody Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Human Sales Growth and Price

10.2.1 Global Human Sales Growth (2013-2018)

10.2.2 Global Human Price (2013-2018)

10.3 Humanized Sales Growth and Price

10.3.1 Global Humanized Sales Growth (2013-2018)

10.3.2 Global Humanized Price (2013-2018)

10.4 Chimeric Sales Growth and Price

10.4.1 Global Chimeric Sales Growth (2013-2018)

10.4.2 Global Chimeric Price (2013-2018)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2013-2018)

10.5.2 Global Others Price (2013-2018)

11 Global Monoclonal Antibody Therapeutics Market Segment by Application

11.1 Global Monoclonal Antibody Therapeutics Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Clinics Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Monoclonal Antibody Therapeutics Market Forecast (2018-2023)

12.1 Global Monoclonal Antibody Therapeutics Sales, Revenue and Growth Rate (2018-2023)

12.2 Monoclonal Antibody Therapeutics Market Forecast by Regions (2018-2023)

12.2.1 North America Monoclonal Antibody Therapeutics Market Forecast (2018-2023)

12.2.2 Europe Monoclonal Antibody Therapeutics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Forecast (2018-2023)

12.2.4 South America Monoclonal Antibody Therapeutics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Monoclonal Antibody Therapeutics Market Forecast (2018-2023)

12.3 Monoclonal Antibody Therapeutics Market Forecast by Type (2018-2023)

12.3.1 Global Monoclonal Antibody Therapeutics Sales Forecast by Type (2018-2023)

12.3.2 Global Monoclonal Antibody Therapeutics Market Share Forecast by Type (2018-2023)

12.4 Monoclonal Antibody Therapeutics Market Forecast by Application (2018-2023)

12.4.1 Global Monoclonal Antibody Therapeutics Sales Forecast by Application (2018-2023)

12.4.2 Global Monoclonal Antibody Therapeutics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Monoclonal Antibody Therapeutics Picture

Table Product Specifications of Monoclonal Antibody Therapeutics

Figure Global Sales Market Share of Monoclonal Antibody The

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery